ZEALAND PHARMA A/S ORD by Zealand Pharma A/S (ZLDPF) Stock Price, Quote, News & History

Key Statistics

Open

Volume / Avg.

0 / 1.02K

Day Range

- - -

52 Wk Range

35.93 - 83.12

Market Cap

P/E Ratio

7.16

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

414.76

Recent Zealand Pharma A/S News

Less Volume, More Premium: Post-Ozempic Economics Are Killing The Quantity Model

As millions take GLP-1 drugs, packaged food giants face declining volumes while protein brands and specialty grocers win.

Stjepan Kalinic

Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names

The $200B GLP-1 market is set to expand with 16 new obesity drugs launching by 2029, challenging Novo Nordisk and Eli Lilly's dominance while addressing scalability and pricing concerns.

Vandana Singh

Recent Price Trend in Zealand Pharma AS is Your Friend, Here's Why

While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the sustainability of a trend isn't easy.

Zacks

International Small-Cap ETF Reaches 52-Week High, Leaving Investors Wondering What's Next

SCZ, an ETF tracking small-caps outside of NA, hits 52-wk high at $65.60. Strong performance of top holdings and bullish trends point to continued success.

Surbhi Jain

Move Aside Ozempic, WeGovy: Denmark's New Drug Just Showed Positive Results For Weightloss

As per the official press release, the 16-week trial aimed to evaluate the safety, tolerability, and clinical effects of the drug called petrelintide.

Benzinga Neuro

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-1.75B

Investing Cash Flow (TTM)

-1.12B

Financing Cash Flow (TTM)

-510.18M

Free Cash Flow (TTM)

-1.83B

Capital Expenditure (TTM)

-78.07M

Net Change in Cash (TTM)

-3.38B

Valuation Metrics

Enterprise Value

$763.16M

PE Ratio (TTM)

7.16

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

4.29

PB Ratio (TTM)

1.05

Earnings Yield % (TTM)

13.97%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

1.71

Price / EBITDA (TTM)

6.87

Price / Free Cash Flow (TTM)

Book Value / Share

$40.95

Company Debt

Total Debt

$312.00M

LT Debt

$312.00M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$4.04B

Debt to Equity

0.02

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

0 / 1.02K

Day Range

- - -

52 Wk Range

35.93 - 83.12

Market Cap

P/E Ratio

7.16

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

414.76

About

Sector

Health Care

Industry

Biotechnology

Zealand Pharma AS is a biotechnology company. It is focused on the discovery, design, and development of peptide-based medicines. The company's product pipeline includes three product candidates in clinical development: glepaglutide, which is being d...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

ZLDPF

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

ZLDPF

FAQ

How do I buy ZEALAND PHARMA A/S ORD by Zealand Pharma A/S (ZLDPF) stock?

You can purchase shares of ZEALAND PHARMA A/S ORD by Zealand Pharma A/S (OTCPK:ZLDPF) through any online brokerage.

View our list of the best stock brokerages

Who are ZEALAND PHARMA A/S ORD by Zealand Pharma A/S (ZLDPF) competitors?

There are no as such competitors for ZEALAND PHARMA A/S ORD by Zealand Pharma A/S.

What is the forecast, or price target, for ZEALAND PHARMA A/S ORD by Zealand Pharma A/S (ZLDPF) stock?

There is no analysis for ZEALAND PHARMA A/S ORD by Zealand Pharma A/S to provide a consensus price target.

What is the current price for ZEALAND PHARMA A/S ORD by Zealand Pharma A/S (ZLDPF)?

The stock price for ZEALAND PHARMA A/S ORD by Zealand Pharma A/S (OTCPK: ZLDPF) is $43 last updated September 14, 2026 at 1:29 PM EDT.

Does ZEALAND PHARMA A/S ORD by Zealand Pharma A/S (ZLDPF) pay a dividend?

There are no upcoming dividends for ZEALAND PHARMA A/S ORD by Zealand Pharma A/S.

When is ZEALAND PHARMA A/S ORD by Zealand Pharma A/S (OTCPK:ZLDPF) reporting earnings?

ZEALAND PHARMA A/S ORD by Zealand Pharma A/S does not have any upcoming earnings scheduled.

Is ZEALAND PHARMA A/S ORD by Zealand Pharma A/S (ZLDPF) going to split?

There is no upcoming split for ZEALAND PHARMA A/S ORD by Zealand Pharma A/S.

What sector and industry does ZEALAND PHARMA A/S ORD by Zealand Pharma A/S (ZLDPF) operate in?

ZEALAND PHARMA A/S ORD by Zealand Pharma A/S is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.